667 THE EFFECT OF PRENATAL ACETYL SALICYLIC ACID (ASA) INGESTION ON MATERNAL AND NEONATAL HEMOSTASIS
| Autor: | J E Graeber, Steven J. Gross, H Elrad, Marie J. Stuart, Fredrick R. Davey, M T Cabalum |
|---|---|
| Rok vydání: | 1978 |
| Předmět: | |
| Zdroj: | Pediatric Research. 12:475-475 |
| ISSN: | 1530-0447 0031-3998 |
| DOI: | 10.1203/00006450-197804001-00672 |
| Popis: | The effect of prenatal ASA ingestion on hemostasis was investigated in 59 maternal-neonate pairs. Group I consisted of 36 control pairs in whom a negative ASA drug history was substantiated by normal maternal and neonatal platelet aggregations and values for the prostaglandin byproduct malonyldialdehyde (MDA). Group II consisted of 16 pairs in whom a positive history for maternal ASA ingestion was confirmed by the expected abnormalities in platelet aggregations and MDA. Group III comprised 7 maternal-neonate pairs where maternal ASA ingestion occurred within 6 hours post partum. All groups were evaluated for hemostatic abnormalities. Maternal blood loss was considered excessive, if a drop of >10% between initial and discharge hemoglobin occurred (vaginal delivery), or >25% (C section). In Group I, no maternal hemostatic abnormalities were noted, although 1/34 neonates demonstrated facial ecchymoses. In 10/16 Group II pairs where maternal ASA ingestion had occurred 0-5 days prior to delivery, clinical evidence of bleeding occurred in 90% (9/10) of the infants, and 60% (6/10) of the mothers. In contrast, in 6/16 Group II pairs, where ASA ingestion had occurred 6-10 days prior to delivery, no abnormalities were found. Group III infants were normal, although 57% (4/7) mothers in this group bled abnormally. ASA ingested in the 5 days prior to delivery, or immediately post partum, is associated with hemostatic abnormalities in both mother and neonate. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|